Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers
Trial Summary
What is the purpose of this trial?
This trial compares two tablets, VHX-896 and Iloperidone, to see if they work the same way in healthy people. Healthy volunteers are used to ensure clear results. The study measures how similarly the body absorbs and processes both tablets. Iloperidone is a medication approved several years ago for the treatment of schizophrenia in adults.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, since the study involves healthy volunteers, it's possible that you may need to pause certain medications. Please consult with the trial coordinators for specific guidance.
What safety data exists for Iloperidone (also known as VHX-896) in humans?
What data supports the effectiveness of the drug Iloperidone, VHX-896?
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single oral dose of VHX-896 or iloperidone in a two-period crossover design
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Iloperidone
- VHX-896
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanda Pharmaceuticals
Lead Sponsor